Your browser doesn't support javascript.
loading
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Serrano, C; Bauer, S; Gómez-Peregrina, D; Kang, Y-K; Jones, R L; Rutkowski, P; Mir, O; Heinrich, M C; Tap, W D; Newberry, K; Grassian, A; Shi, H; Bialick, S; Schöffski, P; Pantaleo, M A; von Mehren, M; Trent, J C; George, S.
Afiliação
  • Serrano C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: cserrano@vhio.net.
  • Bauer S; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, DKTK-Partner-Site, University of Duisburg-Essen, Essen, Germany.
  • Gómez-Peregrina D; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Jones RL; Royal Marsden Hospital and Institute of Cancer Research, London, UK.
  • Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Mir O; Institut Gustave Roussy, Villejuif, France.
  • Heinrich MC; Portland VA Health Care System and OHSU Knight Cancer Institute, Portland.
  • Tap WD; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York.
  • Newberry K; Blueprint Medicines Corporation, Cambridge.
  • Grassian A; Blueprint Medicines Corporation, Cambridge.
  • Shi H; Blueprint Medicines Corporation, Cambridge.
  • Bialick S; Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.
  • Schöffski P; Department of General Medicine Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Pantaleo MA; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • von Mehren M; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia.
  • Trent JC; Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.
  • George S; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Boston, USA.
Ann Oncol ; 34(7): 615-625, 2023 07.
Article em En | MEDLINE | ID: mdl-37105265
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / DNA Tumoral Circulante / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / DNA Tumoral Circulante / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article